Novocure Ltd ( NVCR) - Key Metrics
NVCR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $1.66 | -$0.09 | $0.19 | $0.13 |
| 2026Q2 | $1.58 | -$0.13 | $0.11 | $0.05 |
| 2026Q1 | $1.52 | -$0.62 | -$0.12 | -$0.16 |
| 2025Q4 | $1.56 | -$0.22 | -$0.16 | -$0.21 |
| 2025Q3 | $1.49 | -$0.33 | $0.18 | $0.13 |
NVCR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | -44.31 |
| 2026Q2 | 0% | -29.13 |
| 2026Q1 | 0% | -4.40 |
| 2025Q4 | 0% | -14.69 |
| 2025Q3 | 0% | -9.79 |
NVCR Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 0.85% | 0% |
| 2026Q2 | 0.31% | 0% |
| 2026Q1 | -1.50% | 0% |
| 2025Q4 | -1.59% | 0% |
| 2025Q3 | 1.03% | 0% |
NVCR
Price: $13.50
52 week price:
Earnings Per Share: -1.06 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: Jersey
Volume: 542600
Ebitda: -3.9 millionMarket Capitalization: 1.5 billion